Innovative therapy in clinical practice: Ethical perspective from China

Area of Science:

• Medical Ethics
• Health Policy
• Biotechnology

Background:

• Innovative therapy represents a new medical intervention paradigm, deviating from standard practice.
• Its application is increasing in China with medical technology advancements.
• Standard treatments may fail, necessitating alternative therapeutic pathways for patients.

Purpose of the Study:

• To elucidate the concept of innovative therapy.
• To critically examine ethical challenges within the Chinese clinical context.
• To propose guidelines and a regulatory framework for responsible utilization.

Main Methods:

• Conceptual analysis of innovative therapy.
• Critical examination of ethical challenges in the Chinese clinical setting.
• Literature review on regulatory strategies and patient best interests.

Main Results:

• Innovative therapy presents ethical challenges: misconceptions (research vs. therapy), benefit-risk assessment complexities, conflicts of interest, and regulatory barriers.
• Patient best interests are paramount in the application of innovative therapies.
• Existing regulatory strategies face barriers to effective development.

Conclusions:

• Establishing guidelines and an adaptable regulatory framework is crucial for addressing unmet patient needs and mitigating risks.
• Ethical insights from China can inform the development and responsible utilization of innovative therapy globally.
• A balanced approach is needed to foster innovation while ensuring patient safety and ethical practice.